「ept」の検索結果

Predict peptide-MHC class I binding and natural presentation with MHCflurry, NetMHCpan-4.1, and MixMHCpred to nominate candidate CD8 T-cell epitopes. Covers the binding-affinity (BA) vs eluted-ligand (EL/presentation) distinction, why %Rank beats raw nM for cross-allele work, the MS abundance bias that misranks low-expression neoantigens, allele-coverage inequity, and length bias. Use when scanning a protein or peptide set for class I epitopes, scoring neoantigen candidates, or choosing a binding predictor. For CD4/HLA class II see mhc-class-ii-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Predict peptide-MHC class II (HLA-DR/DQ/DP) binding and presentation for CD4 T-cell epitopes with NetMHCIIpan-4.3 and MixMHC2pred-2.0. Covers why class II is far less reliable than class I (open binding groove, 9-mer register ambiguity, sparse noisy training data, DR>DP>DQ accuracy asymmetry), the DQ/DP heterodimer alpha/beta pairing trap, and the looser 1%/5% %Rank thresholds. Use when predicting CD4 epitopes for vaccine help, mapping class II neoantigens, or scoring long peptides against DR/DQ/DP. For CD8/class I see mhc-binding-prediction.

日本語の概要は準備中です。原文の説明を表示しています。

Calculates statistical power for high-dimensional genomics experiments (bulk RNA-seq, scRNA-seq, ATAC-seq, ChIP-seq, methylation, proteomics) under negative-binomial count models using RNASeqPower, PROPER, and simulation via powsimR, distinguishing per-gene from marginal (transcriptome-wide) power, the role of mean expression and dispersion, and the sequencing-depth-versus-replicate tradeoff. Covers simulation as the honest default for overdispersed counts, FDR-aware average power versus single-test power, observed/post-hoc power as an anti-pattern, and the winner's-curse / Type-S / Type-M consequences of underpowering. Use when planning replicate number for a sequencing experiment, deciding whether to add depth or samples, choosing closed-form versus simulation power, estimating power from pilot dispersions, or justifying replication in a grant. For clinical-trial power see clinical-biostatistics/power-and-sample-size; for the inverse sample-size question see experimental-design/sample-size.

日本語の概要は準備中です。原文の説明を表示しています。

Maps between gene identifier systems (Ensembl, Entrez, HGNC symbol, UniProt, RefSeq, MANE) using AnnotationDbi, biomaRt, mygene, pyensembl, and Ensembl REST. Encodes Ensembl version stripping with GENCODE _PAR_Y preservation, the Ziemann 2016 Excel autocorrect debacle and Bruford 2020 HGNC renames (SEPT*->SEPTIN*, MARCH*->MARCHF*, MARC*->MTARC*, DEC1->DELEC1), OCT4/POU5F1 alias resolution, biomaRt archive endpoints for release pinning, the `filters` (plural) gotcha, MANE Select for clinical reporting, cross-species orthology via Ensembl Compara / OMA / OrthoDB, and tx2gene construction for tximport. Use when converting gene IDs across systems, handling renamed symbols, building tx2gene, pinning to a specific Ensembl release for reproducibility, or mapping cross-species orthologs.

日本語の概要は準備中です。原文の説明を表示しています。

Estimates the minimum biological replicates (or cells/events) for a target power at a target FDR in genomics experiments using ssizeRNA, PROPER, powsimR for scRNA-seq, and pilot-data dispersion estimation from DESeq2/edgeR. Covers the biological-versus-technical replication distinction (technical replicates do not add degrees of freedom for biological inference), replicate-number-versus-sequencing-depth budgeting, scRNA-seq sample-versus-cell allocation under a pseudobulk model, and the critique that "n=3" is a publication convention rather than a power calculation. Use when budgeting a sequencing experiment, writing the sample-size justification in a grant, estimating replicates from pilot data, allocating a fixed budget between samples and depth, or planning scRNA-seq cohort size. For clinical-trial sample size see clinical-biostatistics/power-and-sample-size; for the power-given-n direction see experimental-design/power-analysis.

日本語の概要は準備中です。原文の説明を表示しています。

Detect somatic and germline copy number variants from targeted, exome, and whole-genome sequencing with CNVkit, a read-depth caller that combines on-target and off-target (antitarget) coverage. Covers panel-of-normals construction, flat-reference tumor-only calling, hybrid/amplicon/WGS modes, CBS vs HMM segmentation selection, purity-aware integer calling, and reconciliation against GATK and allele-specific callers. Use when calling CNVs from hybrid-capture panels or exomes, deciding whether CNVkit (depth-only) is the right tool versus an allele-specific caller, building a panel of normals, diagnosing flat-reference false positives, or interpreting log2 ratios into copy-number states.

日本語の概要は準備中です。原文の説明を表示しています。

Builds and applies 3D pharmacophore models using RDKit Pharm3D, the apo2ph4 receptor-based workflow (Heider et al 2022/2023 J Chem Inf Model 63:147-158), Pharmer / Pharmit (search), and PharmacoForge (diffusion-based generation, Flynn et al 2025 Front Bioinform), covering ligand-based pharmacophore (from active set alignment) and receptor-based pharmacophore (from binding pocket geometry). Explicit handling of feature types, geometric tolerances, partial matching, and pharmacophore-based virtual screening. Use when identifying scaffold-hopping candidates, building shape-and-feature search queries, or transferring SAR across chemotypes.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses RNA-seq data quality specifically for alternative splicing analysis. QC layers include experimental design audit (library prep, read length, depth, replicates), STAR 2-pass cohort-style alignment, junction saturation curves and discovery plateau detection, novel-vs-known junction ratio diagnostics, junction-overhang distribution, splice-site strength scoring (MaxEntScan intrinsic + SpliceAI context-aware), strandedness verification, GENCODE basic vs comprehensive choice, and rRNA contamination screening. Splicing analysis is more demanding than DGE on read length, depth, library prep, alignment strategy, and annotation choice — failures silently bias PSI estimates and inflate novel-junction false positives. Use when evaluating data suitability for splicing analysis, troubleshooting low event detection, or designing sequencing experiments where AS is a primary endpoint.

日本語の概要は準備中です。原文の説明を表示しています。

Analyzes differential transcript usage (DTU) and isoform switches with functional consequence prediction (NMD via 50nt rule, ORF disruption, protein domain loss/gain, signal peptide changes, IDR alterations, coding-potential shifts). Tools include IsoformSwitchAnalyzeR v2 (auto-selects satuRn for >5 reps else DEXSeq), the manual DRIMSeq -> DEXSeq/satuRn -> stageR DTU pipeline, and fishpond/swish for inferential-uncertainty-aware DTE. Distinguishes DTU from DGE and DTE; integrates external annotators (CPC2, Pfam, SignalP, IUPred2A or DeepTMHMM). Use when investigating how splicing differences alter protein function or trigger NMD-mediated degradation.

日本語の概要は準備中です。原文の説明を表示しています。

Generate alignment statistics using samtools flagstat, stats, depth, coverage, and mosdepth. Use when assessing alignment quality, calculating coverage, or generating QC reports.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to understand when electronic records are acceptable to FMCSA inspectors. Covers PDF, original-format, and search-ability requirements.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to understand FMCSA tire tread depth requirements. Covers steer tires (4/32 minimum) and other axles (2/32 minimum), and how to measure correctly.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when a driver needs to extend the 14-hour duty window using the 16-hour exception under § 395.1(o). Covers eligibility, frequency limits (once per 7 days), return-to-terminal requirement, and documentation.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when a driver is operating under the 150 air-mile short-haul exception and is asked to produce records. Covers the simplified time records required, when ELD is NOT required, and the documentation that satisfies inspectors.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill to understand the requirement that drivers must self-certify their non-excepted/excepted status with their state driver licensing agency. Covers § 383.71, the four self-cert options, and the state-to-CDL link.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when a driver has vision in only one eye or significantly reduced vision in one eye. Covers § 391.41 vision standards, monocular driver variance, and depth-perception assessment.

日本語の概要は準備中です。原文の説明を表示しています。

Use this skill when hiring a driver who has a recent valid pre-employment test from a prior employer. Covers the conditions under § 382.301(c) that allow accepting it instead of testing again.

日本語の概要は準備中です。原文の説明を表示しています。

Expert in color theory, palette harmony, and perceptual color science for computational photo composition. Specializes in earth-mover distance optimization, warm/cool alternation, diversity-aware palette selection, and hue-based photo sequencing. Activate on "color palette", "color harmony", "warm cool", "earth mover distance", "Wasserstein", "LAB space", "hue sorted", "palette matching". NOT for basic RGB manipulation (use standard image processing), single-photo color grading (use native-app-designer), UI color schemes (use vaporwave-glassomorphic-ui-designer), or color blindness simulation (accessibility specialists).

日本語の概要は準備中です。原文の説明を表示しています。

Epistemic logic for multi-agent perceptual systems — Kripke models, vision sets, public announcement as coordination primitive, and satisfiability-as-reconfiguration applied to agents with limited observability. From Charrier, Ouchet, Schwarzentruber's "Big Brother Logic" demonstration paper (ENS Rennes / IRISA).

日本語の概要は準備中です。原文の説明を表示しています。

Apply cognitive task analysis to expert work that depends on perceptual cues, branching judgment, and recurring monitoring loops. Use when decomposing expert capability into agent structure, simulation design, or validation interviews. NOT for ordinary step-by-step SOP capture or simple pipelines with no tacit cue layer.

日本語の概要は準備中です。原文の説明を表示しています。

This skill should be used when the user asks to "最小再現環境を作って", "再現環境を構築して", "問題を切り分けたい", "パッケージの不具合か確認したい", "create a minimal reproduction", "isolate the issue", "build a repro environment", "reproduce this bug", "narrow down the cause", "is this a package bug or my code", "このPRの問題を再現して", "this commit broke something", or wants to determine whether a bug is caused by a package, the environment, or application code. Accepts PR URLs, commit hashes, or branch names as input.

Codex Plan Mode 専用。docs/PLAN/{YYMMDD}_{slug}/ に schema v3 仕様書を作成する。 Gate 契約 (Goal / Constraints / Acceptance Criteria)、Mermaid 図、Cursor Agent 委任ヒントを含む。 Trigger: spec-codex

自己完結した実装仕様書を作成する。Gate 単位で Goal / Constraints / Acceptance Criteria を契約として明示し、実装エージェントに委任できる形で渡す。Trigger: 仕様書を作成, /dev:spec, 実装計画, 実装仕様

This skill should be used when agents generate placeholder tokens like "pseudo-", "mock-", "temporary", "TODO", "demo-", or similar incompleteness markers. Detects substitution patterns in agent OUTPUT and triggers mandatory user interview instead of accepting incomplete work. Activates automatically on any output containing forbidden tokens.

日本語の概要は準備中です。原文の説明を表示しています。